NCT04886765 2021-05-14
A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma
AlaMab Therapeutics (Shanghai) Inc.
Phase 1/2 Unknown
AlaMab Therapeutics (Shanghai) Inc.
Peking University People's Hospital
Lee's Pharmaceutical Limited
Tata Memorial Hospital